$39.80
-0.78 (-1.91%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+17.29%
YTD
-6.12%
Open$40.41
Previous Close$40.57
Day High$41.05
Day Low$39.55
52W High$60.91
52W Low$29.46
Volume—
Avg Volume1.18M
Market Cap3.23B
P/E Ratio28.25
EPS$1.40
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$40.85
Below
SMA 200
$34.09
Above
RSI (14)
37.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
+17.7% upside
Current
$39.80
$39.80
Target
$46.85
$46.85
$30.44
$46.85 avg
$57.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 503.70M | 418.46M | 507.99M |
| Net Income | 64.63M | 48.32M | -2,027,984 |
| Profit Margin | 12.8% | 12.2% | -0.4% |
| EBITDA | 63.98M | 50.49M | -2,983,128 |
| Free Cash Flow | — | — | -1,866,923 |
| Rev Growth | +20.4% | +20.4% | +16.6% |
| Debt/Equity | — | — | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |